Literature DB >> 18325832

Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan.

Wen-Chen Li1, Shin-Ru Shih, Yhu-Chering Huang, Guang-Wu Chen, Shih-Cheng Chang, Mei-Jen Hsiao, Kuo-Chien Tsao, Tzou-Yien Lin.   

Abstract

BACKGROUND: Mismatches between circulating and vaccine strains of influenza virus had been observed in Taiwan. A comprehensive clinical and genetic analysis of influenza B viruses-associated important diseases was lacking.
OBJECTIVES: Clinical and phylogenetic analysis of influenza B viruses during an outbreak in Taiwan. STUDY DESIGNS: Clinical manifestations of hospitalized, culture-confirmed patients were analyzed from July 2004 to June 2005. Partial genome sequence analysis of hemagglutinin (HA), neuraminidase (NA), and nonstructural (NS) genes were performed in 54 influenza B isolates during the study period, and nine srandomly chosen isolates during 2000 and 2003.
RESULTS: Three specific diseases were found in these patients, including 13 of encephalitis/encephalopathy, 28 of influenza-associated myositis (IAM), and one of acute respiratory distress syndrome (ARDS). Three phylogenetic groups were identified, including reassortant strains-group 1 (Victoria lineage of HA, Yamagata lineage of NA, clade A of NS), group 2 (Yamagata lineage of HA, Yamagata lineage of NA, clade A of NS), and group 3 (Yamagata lineage of HA, Yamagata lineage of NA, clade B of NS).
CONCLUSIONS: Severe influenza B-associated disease in children was not rare and might be fatal. We offered the evidence of co-circulation of the two HA lineages in the same outbreak.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325832     DOI: 10.1016/j.jcv.2007.11.026

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  23 in total

1.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010.

Authors:  Yi Tan; Wenda Guan; Tommy Tsan-Yuk Lam; Sihua Pan; Shiguan Wu; Yangqing Zhan; Cecile Viboud; Edward C Holmes; Zifeng Yang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 3.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

Review 4.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 5.  Novel Influenza D virus: Epidemiology, pathology, evolution and biological characteristics.

Authors:  Shuo Su; Xinliang Fu; Gairu Li; Fiona Kerlin; Michael Veit
Journal:  Virulence       Date:  2017-08-25       Impact factor: 5.882

6.  Seroprevalence of influenza A and B in German infants and adolescents.

Authors:  Andreas Sauerbrei; R Schmidt-Ott; H Hoyer; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2009-02-05       Impact factor: 3.402

Review 7.  Novel viral vectored vaccines for the prevention of influenza.

Authors:  Teresa Lambe
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

8.  Influenza A(H1N1)pdm09 outbreak detected in inter-seasonal months during the surveillance of influenza-like illness in Pune, India, 2012-2015.

Authors:  Y K Gurav; M S Chadha; B V Tandale; V A Potdar; S D Pawar; P Shil; A R Deoshatwar; R Aarthy; A Bhushan
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

9.  A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.

Authors:  Joseph B Domachowske; Heidemarie Pankow-Culot; Milagros Bautista; Yang Feng; Carine Claeys; Mathieu Peeters; Bruce L Innis; Varsha Jain
Journal:  J Infect Dis       Date:  2013-03-07       Impact factor: 5.226

10.  Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.

Authors:  Jiří Beran; Mathieu Peeters; Walthère Dewé; Jolana Raupachová; Lenka Hobzová; Jeanne-Marie Devaster
Journal:  BMC Infect Dis       Date:  2013-05-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.